Anti-PPAR alpha antibody (ab126285) is a rabbit polyclonal antibody detecting PPAR alpha in Western Blot. Suitable for Human, Mouse.
- Over 20 publications
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 98.98% PBS, 1% BSA
WB | |
---|---|
Human | Tested |
Mouse | Tested |
Rat | Predicted |
Cow | Predicted |
Dog | Predicted |
Gorilla | Predicted |
Macaque monkey | Predicted |
Orangutan | Predicted |
Rabbit | Predicted |
Species | Dilution info | Notes |
---|---|---|
Species Mouse | Dilution info 1 µg/mL | Notes - |
Species Human | Dilution info 1 µg/mL | Notes - |
Species | Dilution info | Notes |
---|---|---|
Species Rat, Rabbit, Cow, Dog, Macaque monkey, Gorilla, Orangutan | Dilution info - | Notes - |
Select an associated product type
Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as a transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2.
NR1C1, PPAR, PPARA, Peroxisome proliferator-activated receptor alpha, PPAR-alpha, Nuclear receptor subfamily 1 group C member 1
Anti-PPAR alpha antibody (ab126285) is a rabbit polyclonal antibody detecting PPAR alpha in Western Blot. Suitable for Human, Mouse.
- Over 20 publications
pH: 7.4
Preservative: 0.02% Sodium azide
Constituents: 98.98% PBS, 1% BSA
We have tested this species and application combination and it works. It is covered by our product promise.
We have not tested this specific species and application combination in-house, but expect it will work. It is covered by our product promise.
This species and application combination has not been tested, but we predict it will work based on strong homology. However, this combination is not covered by our product promise.
We do not recommend this combination. It is not covered by our product promise.
We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.
In the unlikely event of one of our products not working as expected, you are covered by our product promise.
Full details and terms and conditions can be found here:
Terms & Conditions.
All lanes: Western blot - Anti-PPAR alpha antibody (ab126285) at 1 µg/mL
Lane 1: HepG2 (Human hepatocellular liver carcinoma cell line) Whole Cell Lysate at 10 µg
Lane 2: HEK293 (Human embryonic kidney cell line) Whole Cell Lysate at 10 µg
Lane 3: Jurkat (Human T cell lymphoblast-like cell line) Whole Cell Lysate at 10 µg
Lane 4: NIH 3T3 (Mouse embryonic fibroblast cell line) Whole Cell Lysate at 10 µg
All lanes: Western blot - Goat Anti-Rabbit IgG H&L (HRP) preadsorbed (Goat Anti-Rabbit IgG H&L (HRP) preadsorbed ab97080) at 1/5000 dilution
Developed using the ECL technique.
Performed under reducing conditions.
Predicted band size: 52 kDa
Observed band size: 37 kDa, 50 kDa, 52 kDa
Exposure time: 1min
Image collected and cropped by CiteAb under a CC-BY license from the publication
PPAR alpha western blot using anti-PPAR alpha antibody ab126285. Publication image and figure legend from Shao, Z., Koh, W., et al., 2020, Sci Rep, PubMed 32313136.
ab126285 was used in this publication in western blot. This may not be the same as the application(s) guaranteed by Abcam. For a full list of applications guaranteed by Abcam for ab126285 please see the product overview.
Validation of One-month-old Mouse Heart RNA-Sequencing Results by qRT-PCR and Western Blot. Samples (RNAs and proteins) being analyzed were extracted from WT and Lmna−/− mouse heart tissues at 1 month of age. (a) RT-qPCR validation of down-regulated genes (ACDVL, ATP5G1, CRAT, ECH1, KCDN2, P2RY1, PPARA) identified by RNA-Sequencing. The same ∆∆Ct method was used for analysis as described in Fig. 3 legends. The relative expression levels of all the listed genes are showed as “mean ± SEM” on Y axis. The expression levels of all the listed genes among 1-month Lmna−/− mouse hearts were significantly lower than the levels among 1-month WT mouse hearts (p < 0.05). (b) RT-qPCR validation of up-regulated genes (DUSP4, LOX, FHL1, MYOM2, NMRK2) identified by RNA-Sequencing. The same ∆∆Ct method was used for analysis. The relative expression levels of all the listed genes are showed as “mean ± SEM” on Y axis. The expression levels in 1-month Lmna−/− mouse hearts were significantly higher than those in 1-month WT mouse hearts for all the genes (p < 0.05). (c) Western blot validation of protein expressions of representative down-regulated (ECH1 and PPARA) and up-regulated (DUSP4 and FHL1) genes. β-actin (for ECH1 and PPARA) or GAPDH (for DUSP4 and FHL1) was used as a loading control. Three repeated experiments were conducted for each protein with similar results showed in the figure.
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com